Vertex Pharmaceuticals
VRTX
#175
Rank
HK$909.09 B
Marketcap
HK$3,546
Share price
-0.41%
Change (1 day)
-1.37%
Change (1 year)

Earnings for Vertex Pharmaceuticals (VRTX)

Earnings in 2025 (TTM): HK$34.78 Billion

According to Vertex Pharmaceuticals's latest financial reports the company's current earnings are HK$11.72 Billion. In 2024 the company made an earning of HK$2.17 Billion a decrease over its 2023 earnings that were of HK$34.43 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vertex Pharmaceuticals from 1990 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) HK$34.78 B1500.96%
2024 HK$2.17 B-93.69%
2023 HK$34.43 B3.19%
2022 HK$33.37 B53.56%
2021 HK$21.73 B-12.06%
2020 HK$24.71 B118.45%
2019 HK$11.31 B120.64%
2018 HK$5.12 B1473.64%
2017 HK$0.32 B197.6%
2016 HK$0.10 B-102.97%
2015 -HK$3.69 Billion-28.46%
2014 -HK$5.16 Billion-51.5%
2013 -HK$10.63 Billion-30584.68%
2012 HK$34.85 M-95.47%
2011 HK$0.76 B
2009 -HK$4.62 Billion
2007 -HK$3.22 Billion83.1%
2006 -HK$1.76 Billion59.02%
2005 -HK$1.11 Billion3.28%
2004 -HK$1.07 Billion-38.16%
2003 -HK$1.73 Billion
2000 -HK$0.3 Billion-20.38%
1999 -HK$0.38 Billion31.62%
1998 -HK$0.29 Billion91.05%
1997 -HK$0.15 Billion-36.24%
1996 -HK$0.24 Billion12.45%
1995 -HK$0.21 Billion27.4%
1994 -HK$0.17 Billion-1833.33%
1993 HK$9.34 M-112.12%
1992 -HK$77.07 Million175%
1991 -HK$28.03 Million-12.2%
1990 -HK$31.92 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Gilead Sciences
GILD
HK$76.95 B 121.58%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
HK$12.92 B-62.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$179.74 B 417.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$62.53 B 80.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
HK$252.18 B 626.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Enanta Pharmaceuticals
ENTA
-HK$0.68 Billion-101.93%๐Ÿ‡บ๐Ÿ‡ธ USA